UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Will Korean COVID-19 patients get to use remdesivir for compassionate use?
With new outbreaks of the novel coronavirus (COVID-19) spiked in Korea with...
by Kim Yun-mi
|
2020-02-24 17:41
라인
Local researchers find new cause of Parkinson’s disease
A joint research team has discovered that if the function of a causative ge...
by Shim Hyun-tai
|
2020-02-21 18:25
라인
Labor group slams Fresenius for allegedly breaching labor law
The Korean offshoot of Germany-based Fresenius Medical Care has violated em...
by Kim Yun-mi
|
2020-02-21 16:39
라인
‘Favipiravir not approved as new coronavirus drug yet’
Some local news reports said -- mistakenly -- favipiravir, an experimental ...
by Kim Yun-mi
|
2020-02-21 12:08
라인
Theragen Etex marked record-high sales, net profits in 2019
Theragen Etex said Thursday it hit record-high sales of 138.7 billion won (...
by Lee Han-soo
|
2020-02-20 18:48
라인
Regulator OKs Pfizer's Vizimpro as 1st-line treatment of mutated lung cancer
Pfizer Korea said Thursday that the Ministry of Food and Drug Safety has ap...
by Shim Hyun-tai
|
2020-02-20 18:47
라인
Daewoong’s Nabota gets item license in Brazil
Daewoong Pharmaceutical said Thursday that its botulinum product, Nabota, h...
by Shim Hyun-tai
|
2020-02-20 16:11
라인
Drugmakers rush to roll out famotidine to replace ranitidine
Local pharmaceutical companies are quickly releasing medicines containing f...
by Jeong Sae-im
|
2020-02-18 15:07
라인
Medytox's Meditoxin gets new indication for cervical dystonia
Medytox said Tuesday that its botulinum toxin preparation, Meditoxin, has r...
by Shim Hyun-tai
|
2020-02-18 15:06
라인
JW wins US patent for world’s 1st multi-biomarker diagnostic kit
JW Holdings said Monday that it has obtained a patent in the United States ...
by Shim Hyun-tai
|
2020-02-17 17:54
라인
Genexine’s US affiliate gets FDA nod for immune booster trial
NeoImmuneTech, Genexine's affiliate, received approval from the U.S. Fo...
by Shim Hyun-tai
|
2020-02-17 12:46
라인
Helixmith gets mixed results from p3-1 trials of gene therapy
Helixmith said Friday that the clinical trial phase 3-1 result of Engensis ...
by Shim Hyun-tai
|
2020-02-14 18:12
라인
Eisai to pull out antiobesity drug Belviq from US market
Eisai Pharmaceutical, a Japan-based multinational drug firm, has decided to...
by Lee Han-soo
|
2020-02-14 16:38
라인
Daewoong’s sales reached ₩1 trillion milestone in 2019
Daewoong Pharmaceutical said that its sales exceeded 1 trillion won ($845.8...
by Lee Han-soo
|
2020-02-14 14:33
라인
JW Pharmaceutical turns to loss on reduced sales of nutrients
JW Pharmaceutical said it reported operating loss in 2019, turning from an ...
by Jeong Sae-im
|
2020-02-14 12:03
라인
Mediforum turned around to net profit in 2019
Mediforum, a pharmaceutical specialized in developing degenerative brain di...
by Shim Hyun-tai
|
2020-02-13 17:43
라인
Bukwang's dyskinesia treatment gets FDA nod for p 2 trials
The U.S. Food and Drug Administration has recently approved the phase 2 cli...
by Shim Hyun-tai
|
2020-02-13 14:22
라인
Dong-A ST posts robust profit in 2019
Dong-A ST said Thursday that it recorded sales of 612.2 billion won ($518.2...
by Lee Han-soo
|
2020-02-13 14:20
라인
ISU’s US partner releases clinical trial results of new hemophilia treatment
ISU Abxis, an orphan drug developer, said Wednesday that its U.S. partner, ...
by Shim Hyun-tai
|
2020-02-13 11:18
라인
SK Plasma to enter ME market with self-developed tech
SK Plasma has signed a memorandum of understanding with Arab Company for Dr...
by Shim Hyun-tai
|
2020-02-12 17:16
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top